BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11785713)

  • 1. Two new treatment regimens for Helicobacter pylori eradication: a randomised study.
    De Francesco V; Zullo A; Hassan C; Faleo D; Ierardi E; Panella C; Morini S
    Dig Liver Dis; 2001 Nov; 33(8):676-9. PubMed ID: 11785713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
    Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
    Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Ojetti V; Cianci R; Pastorelli A; Armuzzi A; Gentiloni N; Gasbarrini A; Pirozzi G; Gasbarrini G
    Aliment Pharmacol Ther; 2000 Jan; 14(1):73-7. PubMed ID: 10632648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
    Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
    Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new highly effective short-term therapy schedule for Helicobacter pylori eradication.
    Zullo A; Rinaldi V; Winn S; Meddi P; Lionetti R; Hassan C; Ripani C; Tomaselli G; Attili AF
    Aliment Pharmacol Ther; 2000 Jun; 14(6):715-8. PubMed ID: 10848654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
    Choi IJ; Jung HC; Choi KW; Kim JH; Ahn DS; Yang US; Rew JS; Lee SI; Rhee JC; Chung IS; Chung JM; Hong WS
    Aliment Pharmacol Ther; 2002 Jan; 16(1):145-51. PubMed ID: 11856089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
    Gisbert JP; Marcos S; Gisbert JL; Pajares JM
    Helicobacter; 2001 Jun; 6(2):157-62. PubMed ID: 11422472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
    Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
    Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
    Ricciardiello L; Cannizzaro O; D'Angelo A; Ederle A; Gerace G; Iaquinto G; Reina G; Scarpulla G; Spadaccini A; Olivieri A; Tosatto R; Fossi S; Pozzato P; Zagari M; Bazzoli F; Roda E
    Aliment Pharmacol Ther; 1998 Jun; 12(6):533-7. PubMed ID: 9678812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
    Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
    Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
    Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Armuzzi A; Gasbarrini A; Pastorelli A; Papa A; Gasbarrini G
    Dig Dis Sci; 1999 Dec; 44(12):2386-9. PubMed ID: 10630486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial.
    Pieramico O; Zanetti MV; Innerhofer M; Malfertheiner P
    Helicobacter; 1997 Jun; 2(2):92-7. PubMed ID: 9432335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.